Nucleoside Analogues: Chemistry, Biology, and Medical Applications

¡ NATO Science Series A āĻ•āĻŋāĻ¤āĻžāĻĒ 26 ¡ Springer Science & Business Media
āĻ‡āĻŦā§āĻ•
461
āĻĒā§ƒāĻˇā§āĻ āĻž
āĻŽā§‚āĻ˛ā§āĻ¯āĻžāĻ‚āĻ•āĻ¨ āĻ†ā§°ā§ āĻĒā§°ā§āĻ¯āĻžāĻ˛ā§‹āĻšāĻ¨āĻž āĻ¸āĻ¤ā§āĻ¯āĻžāĻĒāĻ¨ āĻ•ā§°āĻž āĻšā§‹ā§ąāĻž āĻ¨āĻžāĻ‡  āĻ…āĻ§āĻŋāĻ• āĻœāĻžāĻ¨āĻ•

āĻāĻ‡ āĻ‡āĻŦā§āĻ•āĻ–āĻ¨ā§° āĻŦāĻŋāĻˇā§Ÿā§‡

This publication contains the Review Lectures given at a joint NATO Advanced Study Institute and a FEB S Advanced Study Course, held at Sogesta (Nr. Urbino), Italy from the 7th - 18th May 1979. The Course entitled "Nucleoside Analogues : Chemistry, Biology and Medical Applications" was held for several reasons. In the past few years, many useful and potentially-useful nucleoside analogues have either reached the stage of clinical use or are undergoing clinical trials. Many more compounds have been synthesised by the organic chemist and little more has been done with them other than possibly a few perfunctory biological tests. This is often due to either a lack of interest or an inadequate knowledge of the testing proced ures available or a lack of communication between the chemist, biochemist, pharmacologist and the clinician such that few compounds receive the testing and evaluation which they deserve. The aim of this meeting was to gather together many of the experts in the different scientific disciplines which are involved in the design, synthesis, testing and clinical use of nucleoside analogues, primarily as anti-viral and anti-cancer agents, and to discuss in depth the fundamental principles of each discipline so that participants could understand each other's problems and be more aware of the information required and that which can be obtained.

āĻāĻ‡ āĻ‡āĻŦā§āĻ•āĻ–āĻ¨āĻ• āĻŽā§‚āĻ˛ā§āĻ¯āĻžāĻ‚āĻ•āĻ¨ āĻ•ā§°āĻ•

āĻ†āĻŽāĻžāĻ• āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻŽāĻ¤āĻžāĻŽāĻ¤ āĻœāĻ¨āĻžāĻ“āĻ•āĨ¤

āĻĒāĻĸāĻŧāĻžā§° āĻ¨āĻŋāĻ°ā§āĻĻā§‡āĻļāĻžā§ąāĻ˛ā§€

āĻ¸ā§āĻŽāĻžā§°ā§āĻŸāĻĢ’āĻ¨ āĻ†ā§°ā§ āĻŸā§‡āĻŦāĻ˛ā§‡āĻŸ
Android āĻ†ā§°ā§ iPad/iPhoneā§° āĻŦāĻžāĻŦā§‡ Google Play Books āĻāĻĒāĻŸā§‹ āĻ‡āĻ¨āĻˇā§āĻŸāĻ˛ āĻ•ā§°āĻ•āĨ¤ āĻ‡ āĻ¸ā§āĻŦāĻ¯āĻŧāĻ‚āĻ•ā§āĻ°āĻŋāĻ¯āĻŧāĻ­āĻžā§ąā§‡ āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻāĻ•āĻžāĻ‰āĻŖā§āĻŸā§° āĻ¸ā§ˆāĻ¤ā§‡ āĻ›āĻŋāĻ‚āĻ• āĻšāĻ¯āĻŧ āĻ†ā§°ā§ āĻ†āĻĒā§āĻ¨āĻŋ āĻ¯'āĻ¤ā§‡ āĻ¨āĻžāĻĨāĻžāĻ•āĻ• āĻ¤'āĻ¤ā§‡āĻ‡ āĻ•ā§‹āĻ¨ā§‹ āĻ…āĻĄāĻŋāĻ…'āĻŦā§āĻ• āĻ…āĻ¨āĻ˛āĻžāĻ‡āĻ¨ āĻŦāĻž āĻ…āĻĢāĻ˛āĻžāĻ‡āĻ¨āĻ¤ āĻļā§āĻ¨āĻŋāĻŦāĻ˛ā§ˆ āĻ¸ā§āĻŦāĻŋāĻ§āĻž āĻĻāĻŋāĻ¯āĻŧā§‡āĨ¤
āĻ˛ā§‡āĻĒāĻŸāĻĒ āĻ†ā§°ā§ āĻ•āĻŽā§āĻĒāĻŋāĻ‰āĻŸāĻžā§°
āĻ†āĻĒā§āĻ¨āĻŋ āĻ•āĻŽā§āĻĒāĻŋāĻ‰āĻŸāĻžā§°ā§° ā§ąā§‡āĻŦ āĻŦā§āĻ°āĻžāĻ‰āĻœāĻžā§° āĻŦā§āĻ¯ā§ąāĻšāĻžā§° āĻ•ā§°āĻŋ Google PlayāĻ¤ āĻ•āĻŋāĻ¨āĻž āĻ…āĻĄāĻŋāĻ…'āĻŦā§āĻ•āĻ¸āĻŽā§‚āĻš āĻļā§āĻ¨āĻŋāĻŦ āĻĒāĻžā§°ā§‡āĨ¤
āĻ‡-ā§°ā§€āĻĄāĻžā§° āĻ†ā§°ā§ āĻ…āĻ¨ā§āĻ¯ āĻĄāĻŋāĻ­āĻžāĻ‡āĻš
Kobo eReadersā§° āĻĻā§°ā§‡ āĻ‡-āĻšāĻŋā§ŸāĻžāĻāĻšā§€ā§° āĻĄāĻŋāĻ­āĻžāĻ‡āĻšāĻ¸āĻŽā§‚āĻšāĻ¤ āĻĒā§āĻŋāĻŦāĻ˛ā§ˆ, āĻ†āĻĒā§āĻ¨āĻŋ āĻāĻŸāĻž āĻĢāĻžāĻ‡āĻ˛ āĻĄāĻžāĻ‰āĻ¨āĻ˛â€™āĻĄ āĻ•ā§°āĻŋ āĻ¸ā§‡āĻ‡āĻŸā§‹ āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻĄāĻŋāĻ­āĻžāĻ‡āĻšāĻ˛ā§ˆ āĻ¸ā§āĻĨāĻžāĻ¨āĻžāĻ¨ā§āĻ¤ā§°āĻŖ āĻ•ā§°āĻŋāĻŦ āĻ˛āĻžāĻ—āĻŋāĻŦāĨ¤ āĻ¸āĻŽā§°ā§āĻĨāĻŋāĻ¤ āĻ‡-ā§°āĻŋāĻĄāĻžā§°āĻ˛ā§ˆ āĻĢāĻžāĻ‡āĻ˛āĻŸā§‹ āĻ•ā§‡āĻ¨ā§‡āĻ•ā§ˆ āĻ¸ā§āĻĨāĻžāĻ¨āĻžāĻ¨ā§āĻ¤ā§° āĻ•ā§°āĻŋāĻŦ āĻœāĻžāĻ¨āĻŋāĻŦāĻ˛ā§ˆ āĻ¸āĻšāĻžāĻ¯āĻŧ āĻ•ā§‡āĻ¨ā§āĻĻā§ā§°āĻ¤ āĻĨāĻ•āĻž āĻ¸āĻŦāĻŋāĻļā§‡āĻˇ āĻ¨āĻŋā§°ā§āĻĻā§‡āĻļāĻžā§ąāĻ˛ā§€ āĻšāĻžāĻ“āĻ•āĨ¤